AIM2-driven inflammasome activation in heart failure

Original Research | By Z Onódi, M Ruppert, D Kucsera et al.

'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial

Original Research | By AS Gamal, H Hara, PW Serruys et al.

Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction

Original Research | By K-P Kresoja, K-P Rommel, R Wachter et al.

Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure

Original Research | By K Liu, B Song, MM Ning et al.

Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction

Clinical Trial | By E Puymirat, G Cayla, for the FLOWER-MI Study Investigators et al.

Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study

Original Research | By K Takahashi, PW Serruys, SYNTAX Extended Survival Study Investigators et al.

Functional Mitral Regurgitation Outcome and Grading in Heart Failure With Reduced Ejection Fraction

Original Research | By G Benfari , C Antoine , B Essayagh et al.

Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trial

Clinical Trial | By N Curzen, Z Nicholas, FORECAST Investigators et al.

Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Original Research | By DS Yuan, Z Gao, JQ Yuan et al.

Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial

Clinical Trial | By D Collison, M Didagelos, M Aetesam-Ur-Rahman et al.